| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipopolysaccharides | 86 | 2022 | 558 | 5.790 |
Why?
|
| Depression | 50 | 2022 | 1715 | 4.870 |
Why?
|
| Motor Activity | 53 | 2024 | 693 | 4.800 |
Why?
|
| Behavior, Animal | 91 | 2023 | 709 | 4.740 |
Why?
|
| Inflammation | 51 | 2024 | 2522 | 4.520 |
Why?
|
| Illness Behavior | 14 | 2023 | 29 | 4.490 |
Why?
|
| Cytokines | 75 | 2023 | 2809 | 4.360 |
Why?
|
| Brain | 100 | 2024 | 4113 | 4.200 |
Why?
|
| Neuroimmunomodulation | 24 | 2021 | 66 | 3.990 |
Why?
|
| Interleukin-1 | 81 | 2019 | 461 | 3.900 |
Why?
|
| Fatigue | 17 | 2023 | 1239 | 3.370 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 21 | 2018 | 69 | 3.320 |
Why?
|
| Kynurenine | 25 | 2022 | 71 | 3.050 |
Why?
|
| Motivation | 20 | 2024 | 499 | 2.980 |
Why?
|
| Microglia | 16 | 2020 | 164 | 2.640 |
Why?
|
| Sick Role | 19 | 2023 | 64 | 2.330 |
Why?
|
| Immune System | 13 | 2018 | 279 | 2.080 |
Why?
|
| Kynurenic Acid | 12 | 2022 | 26 | 2.060 |
Why?
|
| Animals | 348 | 2024 | 59536 | 2.050 |
Why?
|
| Depressive Disorder | 13 | 2018 | 557 | 1.960 |
Why?
|
| Interleukin-6 | 25 | 2021 | 1038 | 1.880 |
Why?
|
| Depressive Disorder, Major | 11 | 2022 | 441 | 1.810 |
Why?
|
| Cisplatin | 7 | 2023 | 2432 | 1.730 |
Why?
|
| Stress, Psychological | 21 | 2020 | 1000 | 1.630 |
Why?
|
| Mice | 159 | 2024 | 34495 | 1.560 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2021 | 35 | 1.560 |
Why?
|
| Quinolinic Acid | 12 | 2022 | 23 | 1.520 |
Why?
|
| Mice, Inbred C57BL | 48 | 2022 | 6942 | 1.510 |
Why?
|
| Social Behavior | 44 | 2011 | 306 | 1.480 |
Why?
|
| Insulin-Like Growth Factor I | 34 | 2011 | 630 | 1.460 |
Why?
|
| Interleukin-10 | 18 | 2023 | 478 | 1.450 |
Why?
|
| Reward | 7 | 2023 | 169 | 1.420 |
Why?
|
| Conditioning, Operant | 19 | 2021 | 48 | 1.400 |
Why?
|
| Receptors, Interleukin-1 | 25 | 2014 | 93 | 1.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 37 | 2012 | 1538 | 1.350 |
Why?
|
| Hippocampus | 21 | 2018 | 915 | 1.310 |
Why?
|
| Head and Neck Neoplasms | 7 | 2024 | 3976 | 1.260 |
Why?
|
| Neurosecretory Systems | 6 | 2020 | 66 | 1.230 |
Why?
|
| Exploratory Behavior | 35 | 2013 | 106 | 1.180 |
Why?
|
| Psychoneuroimmunology | 9 | 2015 | 22 | 1.170 |
Why?
|
| Vasopressins | 11 | 1998 | 62 | 1.130 |
Why?
|
| Rats | 103 | 2020 | 6086 | 1.030 |
Why?
|
| Interleukin-1beta | 9 | 2019 | 300 | 1.010 |
Why?
|
| Neuroendocrinology | 2 | 2022 | 3 | 0.990 |
Why?
|
| Stress, Physiological | 17 | 2022 | 492 | 0.990 |
Why?
|
| Tryptophan | 16 | 2021 | 127 | 0.960 |
Why?
|
| Male | 224 | 2023 | 123000 | 0.950 |
Why?
|
| Immunity | 6 | 2021 | 342 | 0.930 |
Why?
|
| Choice Behavior | 4 | 2018 | 226 | 0.920 |
Why?
|
| Hydrocortisone | 7 | 2018 | 388 | 0.910 |
Why?
|
| Sucrose | 4 | 2021 | 64 | 0.910 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2022 | 26 | 0.890 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2022 | 24 | 0.880 |
Why?
|
| Disease Models, Animal | 34 | 2022 | 7222 | 0.870 |
Why?
|
| Arginine Vasopressin | 19 | 1993 | 60 | 0.850 |
Why?
|
| Feeding Behavior | 13 | 2022 | 808 | 0.840 |
Why?
|
| Avoidance Learning | 25 | 2005 | 94 | 0.840 |
Why?
|
| Reinforcement Schedule | 16 | 2021 | 26 | 0.840 |
Why?
|
| Swine | 41 | 2004 | 1541 | 0.830 |
Why?
|
| Muscle Fatigue | 1 | 2021 | 13 | 0.820 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2011 | 45 | 0.800 |
Why?
|
| Schizophrenia | 6 | 2020 | 369 | 0.790 |
Why?
|
| Consummatory Behavior | 1 | 2021 | 1 | 0.790 |
Why?
|
| Neuroendocrine Cells | 1 | 2020 | 14 | 0.780 |
Why?
|
| Mental Disorders | 5 | 2022 | 862 | 0.770 |
Why?
|
| Body Weight | 31 | 2019 | 1293 | 0.770 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2020 | 203 | 0.760 |
Why?
|
| Receptors, Interleukin-1 Type I | 8 | 2017 | 18 | 0.750 |
Why?
|
| Mood Disorders | 5 | 2018 | 163 | 0.750 |
Why?
|
| Signal Transduction | 40 | 2020 | 11965 | 0.750 |
Why?
|
| Cognitive Dysfunction | 3 | 2021 | 333 | 0.730 |
Why?
|
| Rats, Wistar | 34 | 2020 | 562 | 0.720 |
Why?
|
| Brain Chemistry | 9 | 2011 | 145 | 0.720 |
Why?
|
| Cancer Survivors | 3 | 2022 | 650 | 0.720 |
Why?
|
| Amygdala | 5 | 2014 | 127 | 0.710 |
Why?
|
| Biological Psychiatry | 1 | 2019 | 3 | 0.700 |
Why?
|
| Somatoform Disorders | 3 | 2007 | 61 | 0.700 |
Why?
|
| Injections, Intraventricular | 35 | 2013 | 114 | 0.690 |
Why?
|
| Selenium Compounds | 1 | 2019 | 11 | 0.690 |
Why?
|
| Nitrosative Stress | 1 | 2019 | 3 | 0.690 |
Why?
|
| Serotonin | 9 | 2018 | 264 | 0.680 |
Why?
|
| Lipocalin-2 | 1 | 2019 | 65 | 0.680 |
Why?
|
| Hyperalgesia | 7 | 2020 | 238 | 0.680 |
Why?
|
| C-Reactive Protein | 7 | 2020 | 527 | 0.670 |
Why?
|
| Eating | 17 | 2019 | 421 | 0.670 |
Why?
|
| Drinking | 9 | 2012 | 54 | 0.670 |
Why?
|
| Psycho-Oncology | 1 | 2018 | 6 | 0.670 |
Why?
|
| Wakefulness | 2 | 2016 | 150 | 0.630 |
Why?
|
| Mitochondria | 3 | 2022 | 1282 | 0.630 |
Why?
|
| Physical Exertion | 1 | 2018 | 113 | 0.630 |
Why?
|
| Food | 7 | 2021 | 146 | 0.630 |
Why?
|
| Fever | 10 | 2008 | 497 | 0.630 |
Why?
|
| Resilience, Psychological | 1 | 2018 | 64 | 0.610 |
Why?
|
| Immunity, Innate | 11 | 2010 | 677 | 0.600 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 541 | 0.600 |
Why?
|
| Leucine | 1 | 2018 | 352 | 0.570 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2017 | 155 | 0.570 |
Why?
|
| Neoplasms | 11 | 2024 | 15193 | 0.570 |
Why?
|
| Humans | 149 | 2024 | 261506 | 0.570 |
Why?
|
| Hypothalamus | 11 | 2019 | 255 | 0.570 |
Why?
|
| Papillomaviridae | 2 | 2017 | 624 | 0.560 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2012 | 334 | 0.540 |
Why?
|
| Genes, Mitochondrial | 1 | 2015 | 24 | 0.540 |
Why?
|
| Aging | 15 | 2013 | 1582 | 0.540 |
Why?
|
| Mice, Knockout | 22 | 2020 | 5710 | 0.530 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2017 | 336 | 0.530 |
Why?
|
| Restraint, Physical | 6 | 2022 | 50 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.500 |
Why?
|
| Toll-Like Receptors | 2 | 2014 | 174 | 0.500 |
Why?
|
| Spleen | 13 | 2013 | 676 | 0.490 |
Why?
|
| Anorexia | 6 | 2002 | 143 | 0.470 |
Why?
|
| Interferon-alpha | 8 | 2009 | 889 | 0.470 |
Why?
|
| Saliva | 3 | 2018 | 231 | 0.470 |
Why?
|
| Sex Characteristics | 4 | 2021 | 417 | 0.460 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2017 | 259 | 0.460 |
Why?
|
| Indoles | 2 | 2019 | 1009 | 0.460 |
Why?
|
| Vagus Nerve | 7 | 2005 | 63 | 0.460 |
Why?
|
| Thiazepines | 2 | 2004 | 14 | 0.450 |
Why?
|
| Bipolar Disorder | 6 | 2018 | 376 | 0.440 |
Why?
|
| Interferon-gamma | 16 | 2011 | 1144 | 0.440 |
Why?
|
| Glutamic Acid | 2 | 2014 | 309 | 0.440 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1129 | 0.430 |
Why?
|
| Pituitary-Adrenal System | 15 | 2018 | 97 | 0.420 |
Why?
|
| Rats, Inbred Strains | 35 | 1992 | 410 | 0.420 |
Why?
|
| Pituitary Gland | 11 | 2004 | 150 | 0.420 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.410 |
Why?
|
| Growth Hormone | 11 | 2002 | 226 | 0.410 |
Why?
|
| Injections, Intraperitoneal | 22 | 2011 | 197 | 0.410 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.410 |
Why?
|
| Corticosterone | 20 | 2008 | 119 | 0.410 |
Why?
|
| Arousal | 11 | 1995 | 120 | 0.390 |
Why?
|
| Pain | 8 | 2021 | 1658 | 0.380 |
Why?
|
| Taste | 10 | 2005 | 50 | 0.380 |
Why?
|
| Food Preferences | 5 | 2013 | 119 | 0.380 |
Why?
|
| Diazepam | 10 | 1980 | 39 | 0.370 |
Why?
|
| Antineoplastic Agents | 9 | 2022 | 14289 | 0.370 |
Why?
|
| Memory | 11 | 2007 | 429 | 0.370 |
Why?
|
| Mycobacterium bovis | 7 | 2014 | 67 | 0.370 |
Why?
|
| Appetite | 3 | 2008 | 73 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 7 | 2021 | 4367 | 0.360 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2004 | 1242 | 0.360 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 907 | 0.350 |
Why?
|
| Neurons | 14 | 2021 | 2287 | 0.350 |
Why?
|
| Female | 92 | 2023 | 141928 | 0.350 |
Why?
|
| Alcoholism | 2 | 2018 | 285 | 0.350 |
Why?
|
| Myoblasts | 5 | 2008 | 72 | 0.340 |
Why?
|
| Antidepressive Agents | 6 | 2018 | 332 | 0.340 |
Why?
|
| alpha-Amylases | 1 | 2008 | 20 | 0.340 |
Why?
|
| Animals, Domestic | 4 | 1994 | 40 | 0.340 |
Why?
|
| Macrophage Activation | 5 | 2020 | 148 | 0.340 |
Why?
|
| Ketamine | 1 | 2013 | 234 | 0.340 |
Why?
|
| Cerebral Ventricles | 7 | 2007 | 98 | 0.340 |
Why?
|
| Encephalitis | 6 | 2007 | 143 | 0.340 |
Why?
|
| Macrophages | 11 | 2020 | 1304 | 0.340 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2008 | 67 | 0.330 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2011 | 362 | 0.330 |
Why?
|
| Blood-Brain Barrier | 4 | 2018 | 238 | 0.330 |
Why?
|
| Liver | 6 | 2021 | 2961 | 0.330 |
Why?
|
| Neurosciences | 2 | 2024 | 53 | 0.320 |
Why?
|
| Sialoglycoproteins | 13 | 2005 | 151 | 0.320 |
Why?
|
| Exercise | 1 | 2016 | 1183 | 0.310 |
Why?
|
| Disease | 2 | 2008 | 165 | 0.310 |
Why?
|
| Interleukin-4 | 7 | 2003 | 284 | 0.310 |
Why?
|
| Body Temperature | 10 | 2008 | 158 | 0.310 |
Why?
|
| Endotoxins | 6 | 2019 | 96 | 0.310 |
Why?
|
| RNA, Messenger | 28 | 2017 | 6150 | 0.310 |
Why?
|
| Kynurenine 3-Monooxygenase | 2 | 2017 | 5 | 0.310 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2014 | 176 | 0.310 |
Why?
|
| Conditioning, Classical | 10 | 2004 | 69 | 0.300 |
Why?
|
| Interleukin-2 | 4 | 2004 | 842 | 0.300 |
Why?
|
| Chronic Disease | 7 | 2016 | 1819 | 0.300 |
Why?
|
| Interleukins | 3 | 2004 | 325 | 0.300 |
Why?
|
| Nitric Oxide | 2 | 2010 | 644 | 0.300 |
Why?
|
| Antibody Formation | 5 | 2004 | 383 | 0.300 |
Why?
|
| Recombinant Proteins | 34 | 2019 | 2927 | 0.300 |
Why?
|
| Behavioral Research | 1 | 2006 | 23 | 0.290 |
Why?
|
| Body Temperature Regulation | 5 | 1995 | 38 | 0.290 |
Why?
|
| Immunoglobulin G | 3 | 2009 | 1021 | 0.290 |
Why?
|
| Dominance-Subordination | 6 | 2004 | 19 | 0.290 |
Why?
|
| Mice, Inbred ICR | 16 | 2009 | 239 | 0.280 |
Why?
|
| Anhedonia | 4 | 2015 | 39 | 0.280 |
Why?
|
| Adaptation, Psychological | 8 | 2018 | 764 | 0.280 |
Why?
|
| HIV-1 | 1 | 2011 | 653 | 0.280 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 3 | 2011 | 80 | 0.280 |
Why?
|
| Olfactory Bulb | 2 | 2022 | 119 | 0.280 |
Why?
|
| Enzyme Inhibitors | 7 | 2011 | 1879 | 0.280 |
Why?
|
| Affect | 3 | 2018 | 288 | 0.280 |
Why?
|
| Animal Husbandry | 5 | 2004 | 42 | 0.280 |
Why?
|
| Aggression | 10 | 2004 | 252 | 0.270 |
Why?
|
| Receptors, Cytokine | 4 | 2012 | 176 | 0.270 |
Why?
|
| Corpus Striatum | 4 | 2017 | 104 | 0.260 |
Why?
|
| Central Nervous System | 3 | 2024 | 436 | 0.260 |
Why?
|
| Astrocytes | 11 | 2007 | 368 | 0.260 |
Why?
|
| Cells, Cultured | 26 | 2021 | 5637 | 0.260 |
Why?
|
| Gene Expression Regulation | 16 | 2016 | 4053 | 0.260 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 268 | 0.260 |
Why?
|
| Research | 2 | 2022 | 415 | 0.260 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2004 | 35 | 0.260 |
Why?
|
| Neural Pathways | 3 | 2019 | 298 | 0.250 |
Why?
|
| Autistic Disorder | 1 | 2008 | 319 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 17 | 2013 | 2314 | 0.250 |
Why?
|
| Thymus Gland | 7 | 2002 | 294 | 0.240 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 15 | 2019 | 103 | 0.240 |
Why?
|
| Lung | 3 | 2014 | 3151 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 27 | 2008 | 4938 | 0.240 |
Why?
|
| Neuralgia | 3 | 2017 | 251 | 0.240 |
Why?
|
| Mycobacterium Infections | 2 | 2014 | 49 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-fos | 6 | 2008 | 123 | 0.230 |
Why?
|
| Hypoglycemia | 2 | 2018 | 213 | 0.230 |
Why?
|
| Enzyme Activation | 13 | 2011 | 1764 | 0.230 |
Why?
|
| Swine Diseases | 5 | 1986 | 41 | 0.230 |
Why?
|
| Receptors, Cholecystokinin | 2 | 2000 | 29 | 0.230 |
Why?
|
| Circadian Rhythm | 7 | 2018 | 330 | 0.230 |
Why?
|
| Running | 2 | 2013 | 46 | 0.230 |
Why?
|
| Glucocorticoids | 7 | 2001 | 629 | 0.220 |
Why?
|
| Neuroprotective Agents | 3 | 2021 | 215 | 0.220 |
Why?
|
| Quality of Life | 3 | 2016 | 4532 | 0.220 |
Why?
|
| Receptor, IGF Type 1 | 8 | 2006 | 347 | 0.220 |
Why?
|
| BCG Vaccine | 4 | 2016 | 399 | 0.210 |
Why?
|
| Testosterone | 4 | 1998 | 619 | 0.210 |
Why?
|
| Sensory Receptor Cells | 4 | 2020 | 141 | 0.210 |
Why?
|
| Communicable Diseases | 2 | 2002 | 193 | 0.210 |
Why?
|
| Hormones | 4 | 2018 | 266 | 0.210 |
Why?
|
| Mice, Inbred Strains | 12 | 2004 | 521 | 0.210 |
Why?
|
| Transcriptome | 3 | 2016 | 1859 | 0.210 |
Why?
|
| Social Dominance | 3 | 1992 | 15 | 0.200 |
Why?
|
| Psychotic Disorders | 2 | 2020 | 147 | 0.200 |
Why?
|
| Persian Gulf Syndrome | 1 | 2021 | 14 | 0.200 |
Why?
|
| Neuroprotection | 1 | 2021 | 19 | 0.200 |
Why?
|
| Analysis of Variance | 17 | 2010 | 2307 | 0.200 |
Why?
|
| Vagotomy | 9 | 2000 | 26 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2011 | 261 | 0.200 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 160 | 0.200 |
Why?
|
| Chocolate | 1 | 2021 | 1 | 0.200 |
Why?
|
| Synaptic Transmission | 3 | 2021 | 443 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2018 | 901 | 0.200 |
Why?
|
| Hematopoiesis | 6 | 2002 | 560 | 0.200 |
Why?
|
| Prolactin | 5 | 1993 | 155 | 0.200 |
Why?
|
| Orchiectomy | 6 | 1993 | 214 | 0.200 |
Why?
|
| Receptors, Opioid, mu | 1 | 2021 | 86 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 11 | 2012 | 1678 | 0.190 |
Why?
|
| Drug Interactions | 7 | 2013 | 553 | 0.190 |
Why?
|
| Smell | 2 | 1993 | 125 | 0.190 |
Why?
|
| Spinal Cord | 3 | 2015 | 690 | 0.190 |
Why?
|
| Swimming | 5 | 2011 | 27 | 0.190 |
Why?
|
| Neuropsychological Tests | 4 | 2014 | 1178 | 0.190 |
Why?
|
| Receptors, Chemokine | 2 | 2010 | 114 | 0.190 |
Why?
|
| Social Environment | 4 | 2004 | 176 | 0.180 |
Why?
|
| Cognition | 3 | 2018 | 968 | 0.180 |
Why?
|
| Mercaptoethylamines | 1 | 2019 | 4 | 0.170 |
Why?
|
| Pain Threshold | 2 | 2011 | 130 | 0.170 |
Why?
|
| Random Allocation | 3 | 2019 | 703 | 0.170 |
Why?
|
| Zika Virus Infection | 1 | 2021 | 166 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2009 | 184 | 0.170 |
Why?
|
| Macrophages, Peritoneal | 4 | 2015 | 66 | 0.170 |
Why?
|
| Amifostine | 1 | 2019 | 97 | 0.170 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2018 | 24 | 0.160 |
Why?
|
| Neurites | 1 | 2018 | 63 | 0.160 |
Why?
|
| Probiotics | 2 | 2018 | 228 | 0.160 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2018 | 62 | 0.160 |
Why?
|
| Myogenin | 6 | 2008 | 33 | 0.160 |
Why?
|
| Radiation-Protective Agents | 1 | 2019 | 128 | 0.160 |
Why?
|
| Prebiotics | 1 | 2018 | 34 | 0.160 |
Why?
|
| Adult | 23 | 2018 | 77950 | 0.160 |
Why?
|
| Receptors, GABA | 1 | 2018 | 17 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 6 | 2006 | 1491 | 0.160 |
Why?
|
| Organ Size | 4 | 2015 | 690 | 0.160 |
Why?
|
| Inflammation Mediators | 5 | 2007 | 423 | 0.160 |
Why?
|
| Extinction, Psychological | 7 | 1986 | 31 | 0.160 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 1270 | 0.160 |
Why?
|
| Adrenocorticotropic Hormone | 10 | 1999 | 156 | 0.160 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2017 | 24 | 0.160 |
Why?
|
| Immobility Response, Tonic | 3 | 2013 | 5 | 0.150 |
Why?
|
| Sleep Wake Disorders | 2 | 2021 | 348 | 0.150 |
Why?
|
| Peptides | 3 | 2011 | 1479 | 0.150 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2008 | 301 | 0.150 |
Why?
|
| Mental Recall | 4 | 2016 | 171 | 0.150 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2017 | 8 | 0.150 |
Why?
|
| Gray Matter | 2 | 2015 | 63 | 0.150 |
Why?
|
| Biomarkers | 9 | 2018 | 5047 | 0.150 |
Why?
|
| Electroshock | 14 | 1988 | 46 | 0.150 |
Why?
|
| Gene Expression | 10 | 2015 | 3570 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 9 | 1983 | 544 | 0.150 |
Why?
|
| Cerebral Cortex | 6 | 2015 | 621 | 0.150 |
Why?
|
| Fear | 7 | 1982 | 254 | 0.150 |
Why?
|
| Acetylation | 1 | 2018 | 508 | 0.150 |
Why?
|
| Stereotyped Behavior | 2 | 1987 | 35 | 0.150 |
Why?
|
| Benzodiazepinones | 5 | 2000 | 12 | 0.140 |
Why?
|
| Cold Temperature | 2 | 1995 | 121 | 0.140 |
Why?
|
| Time Factors | 25 | 2013 | 12926 | 0.140 |
Why?
|
| Appetite Regulation | 2 | 2002 | 41 | 0.140 |
Why?
|
| Memory, Episodic | 1 | 2016 | 32 | 0.140 |
Why?
|
| Food Deprivation | 7 | 1992 | 47 | 0.140 |
Why?
|
| NF-kappa B | 6 | 2005 | 1549 | 0.140 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2015 | 3 | 0.140 |
Why?
|
| Psychomotor Performance | 3 | 2016 | 233 | 0.140 |
Why?
|
| Interleukin-3 | 4 | 2003 | 96 | 0.140 |
Why?
|
| Leukocytes | 3 | 1996 | 422 | 0.140 |
Why?
|
| Comorbidity | 2 | 2013 | 2352 | 0.140 |
Why?
|
| Frustration | 4 | 1987 | 14 | 0.140 |
Why?
|
| Neuropeptides | 2 | 1994 | 154 | 0.140 |
Why?
|
| Animal Welfare | 2 | 2004 | 38 | 0.130 |
Why?
|
| Exosomes | 1 | 2018 | 253 | 0.130 |
Why?
|
| Animals, Newborn | 8 | 2009 | 1338 | 0.130 |
Why?
|
| Psychophysiologic Disorders | 1 | 1995 | 29 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 1 | 1996 | 151 | 0.130 |
Why?
|
| Antioxidants | 1 | 2019 | 507 | 0.130 |
Why?
|
| Epinephrine | 3 | 2011 | 255 | 0.130 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 393 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2017 | 263 | 0.130 |
Why?
|
| Progesterone | 1 | 1998 | 513 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2005 | 1073 | 0.130 |
Why?
|
| Dexamethasone | 6 | 2001 | 1450 | 0.130 |
Why?
|
| Malignant Hyperthermia | 3 | 1981 | 23 | 0.130 |
Why?
|
| Growth Substances | 1 | 1996 | 300 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2023 | 935 | 0.130 |
Why?
|
| Up-Regulation | 6 | 2017 | 2450 | 0.130 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 1994 | 22 | 0.130 |
Why?
|
| Infusions, Intraventricular | 2 | 2011 | 29 | 0.130 |
Why?
|
| Insulin | 3 | 2018 | 1454 | 0.130 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 1994 | 32 | 0.130 |
Why?
|
| Exercise Therapy | 2 | 2017 | 288 | 0.130 |
Why?
|
| Schizophrenic Psychology | 1 | 2015 | 102 | 0.120 |
Why?
|
| Drug Administration Schedule | 3 | 2013 | 3472 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 1217 | 0.120 |
Why?
|
| Survivors | 2 | 2021 | 1031 | 0.120 |
Why?
|
| Limbic System | 3 | 2000 | 29 | 0.120 |
Why?
|
| Chemokine CX3CL1 | 2 | 2010 | 9 | 0.120 |
Why?
|
| Phosphorylation | 15 | 2008 | 4804 | 0.120 |
Why?
|
| Cyclin A | 2 | 2004 | 47 | 0.120 |
Why?
|
| GTP Cyclohydrolase | 1 | 2014 | 7 | 0.120 |
Why?
|
| Neurocognitive Disorders | 1 | 1994 | 69 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 803 | 0.120 |
Why?
|
| Pituitary Gland, Anterior | 3 | 2006 | 30 | 0.120 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 360 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2015 | 229 | 0.120 |
Why?
|
| Estrogens | 1 | 1998 | 751 | 0.120 |
Why?
|
| Phenylalanine | 1 | 2014 | 142 | 0.120 |
Why?
|
| Neurons, Afferent | 1 | 1994 | 122 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 342 | 0.120 |
Why?
|
| Parkinsonian Disorders | 2 | 2005 | 77 | 0.120 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 51 | 0.120 |
Why?
|
| Receptors, Immunologic | 2 | 1992 | 309 | 0.110 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2015 | 363 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 855 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 482 | 0.110 |
Why?
|
| Punishment | 4 | 1978 | 10 | 0.110 |
Why?
|
| Dinoprostone | 2 | 2012 | 208 | 0.110 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 285 | 0.110 |
Why?
|
| Pyrogens | 3 | 2000 | 5 | 0.110 |
Why?
|
| Receptors, HIV | 1 | 2012 | 4 | 0.110 |
Why?
|
| Neuropsychology | 1 | 1993 | 33 | 0.110 |
Why?
|
| Nasal Septum | 1 | 1993 | 47 | 0.110 |
Why?
|
| Apoptosis | 8 | 2003 | 7591 | 0.110 |
Why?
|
| Endorphins | 5 | 1985 | 21 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 2013 | 70 | 0.110 |
Why?
|
| Drinking Behavior | 4 | 1988 | 14 | 0.110 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2012 | 25 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 5 | 2018 | 127 | 0.110 |
Why?
|
| Middle Aged | 17 | 2018 | 86204 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 368 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2004 | 2326 | 0.110 |
Why?
|
| Androgens | 3 | 1993 | 511 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2013 | 95 | 0.110 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 1519 | 0.110 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2013 | 151 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2019 | 1996 | 0.100 |
Why?
|
| Social Isolation | 2 | 1984 | 64 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 2 | 2005 | 29 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 1371 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 1586 | 0.100 |
Why?
|
| Hindlimb Suspension | 4 | 2013 | 13 | 0.100 |
Why?
|
| Septum Pellucidum | 2 | 1988 | 11 | 0.100 |
Why?
|
| Energy Intake | 3 | 2001 | 515 | 0.100 |
Why?
|
| Tyrosine | 7 | 2014 | 498 | 0.100 |
Why?
|
| Hypophysectomy | 5 | 1996 | 27 | 0.100 |
Why?
|
| Immune Tolerance | 3 | 1989 | 403 | 0.100 |
Why?
|
| Thirst | 2 | 1988 | 7 | 0.100 |
Why?
|
| Vaccination | 2 | 2008 | 1123 | 0.100 |
Why?
|
| Nerve Degeneration | 3 | 2005 | 148 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 3 | 2004 | 104 | 0.100 |
Why?
|
| Histones | 1 | 2018 | 1466 | 0.100 |
Why?
|
| Dominance, Cerebral | 1 | 1990 | 81 | 0.100 |
Why?
|
| Dopamine | 5 | 2005 | 312 | 0.100 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2010 | 32 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.100 |
Why?
|
| Blotting, Western | 8 | 2016 | 3536 | 0.100 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2010 | 33 | 0.090 |
Why?
|
| Interpersonal Relations | 2 | 1994 | 290 | 0.090 |
Why?
|
| Retinoblastoma Protein | 2 | 2003 | 335 | 0.090 |
Why?
|
| Receptors, Interleukin-1 Type II | 5 | 2005 | 6 | 0.090 |
Why?
|
| Nitrites | 1 | 2010 | 61 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2004 | 3022 | 0.090 |
Why?
|
| Defense Mechanisms | 1 | 1990 | 22 | 0.090 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 3869 | 0.090 |
Why?
|
| Colonic Diseases, Functional | 1 | 1990 | 16 | 0.090 |
Why?
|
| Cell Line | 13 | 2010 | 5114 | 0.090 |
Why?
|
| Physical Conditioning, Animal | 1 | 2011 | 112 | 0.090 |
Why?
|
| Cattle | 6 | 2004 | 783 | 0.090 |
Why?
|
| Melanoma | 3 | 2004 | 5317 | 0.090 |
Why?
|
| Lead Poisoning | 2 | 1980 | 12 | 0.090 |
Why?
|
| Drug Resistance | 2 | 2010 | 587 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 848 | 0.090 |
Why?
|
| Cognition Disorders | 3 | 2016 | 786 | 0.090 |
Why?
|
| Emotions | 3 | 2004 | 562 | 0.090 |
Why?
|
| Morphine | 3 | 1987 | 308 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2010 | 358 | 0.090 |
Why?
|
| Cell Cycle Proteins | 3 | 2004 | 2045 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 159 | 0.090 |
Why?
|
| HL-60 Cells | 5 | 2004 | 302 | 0.090 |
Why?
|
| Adiposity | 1 | 2011 | 237 | 0.090 |
Why?
|
| Receptor Cross-Talk | 3 | 2004 | 79 | 0.090 |
Why?
|
| Ganglia, Spinal | 3 | 2020 | 237 | 0.090 |
Why?
|
| Escherichia coli | 6 | 2005 | 1203 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2009 | 142 | 0.080 |
Why?
|
| Memory Disorders | 2 | 2004 | 295 | 0.080 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2008 | 34 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2011 | 3639 | 0.080 |
Why?
|
| Stroke | 1 | 2017 | 1144 | 0.080 |
Why?
|
| Cholecystokinin | 4 | 2005 | 45 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 77 | 0.080 |
Why?
|
| Bone Marrow Cells | 4 | 2002 | 943 | 0.080 |
Why?
|
| Sexual Behavior, Animal | 2 | 1999 | 65 | 0.080 |
Why?
|
| Neurotransmitter Agents | 3 | 2021 | 159 | 0.080 |
Why?
|
| Dextroamphetamine | 1 | 1988 | 18 | 0.080 |
Why?
|
| Neopterin | 1 | 2007 | 13 | 0.080 |
Why?
|
| Cell Differentiation | 10 | 2008 | 4078 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 5159 | 0.080 |
Why?
|
| Superoxides | 3 | 1994 | 211 | 0.080 |
Why?
|
| Acute-Phase Reaction | 1 | 2007 | 26 | 0.080 |
Why?
|
| Publishing | 1 | 2010 | 220 | 0.080 |
Why?
|
| Prostaglandins | 3 | 1993 | 77 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 28 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2008 | 259 | 0.080 |
Why?
|
| Appetitive Behavior | 4 | 2001 | 18 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2008 | 83 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2008 | 90 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2008 | 1265 | 0.080 |
Why?
|
| Pneumonia | 1 | 2014 | 751 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2004 | 2488 | 0.080 |
Why?
|
| Crowding | 1 | 1987 | 8 | 0.080 |
Why?
|
| Naloxone | 5 | 1987 | 82 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2009 | 548 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2016 | 1823 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 4654 | 0.080 |
Why?
|
| CX3C Chemokine Receptor 1 | 3 | 2012 | 23 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 280 | 0.080 |
Why?
|
| Neurophysins | 1 | 1987 | 4 | 0.080 |
Why?
|
| Mastication | 1 | 1987 | 19 | 0.070 |
Why?
|
| Personality Inventory | 2 | 2005 | 178 | 0.070 |
Why?
|
| Mice, Inbred C3H | 6 | 1998 | 385 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 3251 | 0.070 |
Why?
|
| Weight Loss | 3 | 2008 | 627 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 215 | 0.070 |
Why?
|
| Cyclosporins | 1 | 1987 | 112 | 0.070 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2006 | 62 | 0.070 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2015 | 1105 | 0.070 |
Why?
|
| Saccharin | 2 | 2005 | 4 | 0.070 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 244 | 0.070 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 1992 | 82 | 0.070 |
Why?
|
| Chemoradiotherapy | 1 | 2015 | 1946 | 0.070 |
Why?
|
| Down-Regulation | 5 | 2010 | 2074 | 0.070 |
Why?
|
| Estrous Cycle | 1 | 2006 | 37 | 0.070 |
Why?
|
| Young Adult | 5 | 2016 | 21445 | 0.070 |
Why?
|
| Reference Values | 4 | 1993 | 1099 | 0.070 |
Why?
|
| Hepatitis C | 2 | 2009 | 524 | 0.070 |
Why?
|
| Pain Management | 1 | 2012 | 668 | 0.070 |
Why?
|
| Pain Measurement | 2 | 2011 | 953 | 0.070 |
Why?
|
| Anxiety | 3 | 2021 | 1179 | 0.070 |
Why?
|
| Halothane | 3 | 1981 | 21 | 0.070 |
Why?
|
| Vanadium Compounds | 1 | 2005 | 2 | 0.070 |
Why?
|
| Phosphoproteins | 5 | 2006 | 1152 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 338 | 0.070 |
Why?
|
| Reaction Time | 5 | 2003 | 234 | 0.070 |
Why?
|
| Macaca mulatta | 1 | 2008 | 717 | 0.070 |
Why?
|
| Maze Learning | 3 | 2016 | 132 | 0.070 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 2006 | 132 | 0.070 |
Why?
|
| Kainic Acid | 1 | 2005 | 32 | 0.070 |
Why?
|
| Cell Survival | 9 | 2004 | 3045 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 2 | 2003 | 143 | 0.070 |
Why?
|
| Tryptophan Oxygenase | 1 | 2005 | 7 | 0.070 |
Why?
|
| MPTP Poisoning | 1 | 2005 | 4 | 0.070 |
Why?
|
| Pentoxifylline | 1 | 2005 | 35 | 0.070 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 80 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 163 | 0.070 |
Why?
|
| Quinine | 1 | 2005 | 8 | 0.070 |
Why?
|
| Interferon Type I | 1 | 1987 | 250 | 0.070 |
Why?
|
| Gene Ontology | 2 | 2016 | 80 | 0.070 |
Why?
|
| Discrimination Learning | 3 | 2005 | 30 | 0.070 |
Why?
|
| Urologic Diseases | 1 | 1986 | 78 | 0.070 |
Why?
|
| Phenylurea Compounds | 2 | 2000 | 580 | 0.070 |
Why?
|
| Brain Diseases | 2 | 2000 | 403 | 0.060 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1987 | 242 | 0.060 |
Why?
|
| Analgesia | 1 | 1986 | 94 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2005 | 105 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 4 | 1989 | 90 | 0.060 |
Why?
|
| Competitive Behavior | 1 | 2004 | 17 | 0.060 |
Why?
|
| Individuality | 1 | 2004 | 58 | 0.060 |
Why?
|
| Genes, fos | 2 | 2001 | 53 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2006 | 441 | 0.060 |
Why?
|
| Immunotherapy | 2 | 2017 | 3341 | 0.060 |
Why?
|
| Adrenal Medulla | 1 | 1984 | 17 | 0.060 |
Why?
|
| Neuroglia | 3 | 2011 | 223 | 0.060 |
Why?
|
| Caspase 1 | 3 | 2001 | 64 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 1489 | 0.060 |
Why?
|
| Protein Biosynthesis | 4 | 2004 | 889 | 0.060 |
Why?
|
| Models, Biological | 2 | 2010 | 3254 | 0.060 |
Why?
|
| Association Learning | 1 | 2004 | 28 | 0.060 |
Why?
|
| Choroid Plexus | 2 | 2001 | 31 | 0.060 |
Why?
|
| Adrenal Cortex | 2 | 1984 | 35 | 0.060 |
Why?
|
| Ceramides | 1 | 2004 | 95 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2006 | 574 | 0.060 |
Why?
|
| Neostriatum | 1 | 2003 | 17 | 0.060 |
Why?
|
| Models, Animal | 2 | 2004 | 664 | 0.060 |
Why?
|
| Muscle Development | 1 | 2004 | 88 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 1121 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2004 | 538 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2003 | 41 | 0.060 |
Why?
|
| Protein Isoforms | 4 | 2016 | 842 | 0.060 |
Why?
|
| Transportation | 2 | 1982 | 50 | 0.060 |
Why?
|
| Myoblasts, Skeletal | 1 | 2003 | 18 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 862 | 0.060 |
Why?
|
| Castration | 4 | 1992 | 122 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 1984 | 92 | 0.060 |
Why?
|
| Attitude | 1 | 2004 | 159 | 0.060 |
Why?
|
| Devazepide | 2 | 2000 | 5 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2007 | 649 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2016 | 7702 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1945 | 0.060 |
Why?
|
| Biology | 1 | 2023 | 75 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2005 | 304 | 0.060 |
Why?
|
| Learning | 3 | 1989 | 403 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2016 | 584 | 0.060 |
Why?
|
| Mice, Inbred DBA | 5 | 1994 | 110 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2023 | 84 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2009 | 26 | 0.050 |
Why?
|
| Visceral Afferents | 1 | 2002 | 8 | 0.050 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 1382 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 5437 | 0.050 |
Why?
|
| Enzyme Induction | 3 | 2009 | 249 | 0.050 |
Why?
|
| Sex Factors | 4 | 2011 | 2139 | 0.050 |
Why?
|
| Infusions, Parenteral | 2 | 1992 | 191 | 0.050 |
Why?
|
| Lymphocytes | 4 | 2004 | 1234 | 0.050 |
Why?
|
| Immunohistochemistry | 9 | 2007 | 7548 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 4821 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 703 | 0.050 |
Why?
|
| Opioid Peptides | 1 | 2021 | 9 | 0.050 |
Why?
|
| Pregnancy | 4 | 2008 | 7573 | 0.050 |
Why?
|
| Gulf War | 1 | 2021 | 8 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 905 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 1999 | 1493 | 0.050 |
Why?
|
| Adolescent | 4 | 2020 | 31252 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2002 | 132 | 0.050 |
Why?
|
| Drug Synergism | 5 | 2009 | 1313 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 7 | 1996 | 3203 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 4143 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 521 | 0.050 |
Why?
|
| Atrophy | 1 | 2022 | 261 | 0.050 |
Why?
|
| Indomethacin | 4 | 1994 | 91 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2001 | 135 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 1982 | 118 | 0.050 |
Why?
|
| Energy Metabolism | 3 | 1997 | 992 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2021 | 100 | 0.050 |
Why?
|
| Monoamine Oxidase | 1 | 1981 | 14 | 0.050 |
Why?
|
| Afferent Pathways | 1 | 2001 | 64 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 586 | 0.050 |
Why?
|
| Kinetics | 6 | 2006 | 2049 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 249 | 0.050 |
Why?
|
| Weaning | 1 | 1981 | 45 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 634 | 0.050 |
Why?
|
| Forecasting | 1 | 2024 | 694 | 0.050 |
Why?
|
| Social Support | 1 | 2004 | 560 | 0.050 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2001 | 54 | 0.050 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1981 | 38 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2019 | 2063 | 0.050 |
Why?
|
| Satiation | 2 | 1978 | 27 | 0.050 |
Why?
|
| Chickens | 3 | 2004 | 523 | 0.050 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2000 | 36 | 0.050 |
Why?
|
| Heart Rate | 2 | 1974 | 737 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2001 | 186 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2010 | 639 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2018 | 1244 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 29902 | 0.050 |
Why?
|
| Granulocytes | 2 | 2000 | 224 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2004 | 549 | 0.050 |
Why?
|
| Receptors, Vasopressin | 3 | 1992 | 22 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2005 | 451 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 1999 | 314 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2001 | 240 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2000 | 52 | 0.050 |
Why?
|
| Norepinephrine | 3 | 2011 | 272 | 0.050 |
Why?
|
| Environment | 2 | 1983 | 190 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 3 | 2011 | 483 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2004 | 5270 | 0.040 |
Why?
|
| Molecular Weight | 4 | 2007 | 629 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2000 | 97 | 0.040 |
Why?
|
| Zika Virus | 1 | 2021 | 144 | 0.040 |
Why?
|
| Transcription, Genetic | 6 | 1999 | 3154 | 0.040 |
Why?
|
| Neuropeptide Y | 1 | 2019 | 47 | 0.040 |
Why?
|
| Aged | 6 | 2018 | 70117 | 0.040 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2019 | 50 | 0.040 |
Why?
|
| Receptors, Interleukin | 4 | 2002 | 97 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2000 | 614 | 0.040 |
Why?
|
| Prediabetic State | 1 | 1999 | 57 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 246 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1999 | 116 | 0.040 |
Why?
|
| Ephrin-B1 | 1 | 2018 | 9 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2018 | 46 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 53 | 0.040 |
Why?
|
| HIV Infections | 1 | 2011 | 2134 | 0.040 |
Why?
|
| Mifepristone | 2 | 1995 | 147 | 0.040 |
Why?
|
| Lymphocyte Activation | 4 | 1988 | 1688 | 0.040 |
Why?
|
| Analgesics | 1 | 2021 | 390 | 0.040 |
Why?
|
| Substance P | 2 | 1998 | 71 | 0.040 |
Why?
|
| Cell Division | 5 | 2004 | 2489 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 4744 | 0.040 |
Why?
|
| Microcephaly | 1 | 2021 | 325 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 190 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2003 | 1620 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 159 | 0.040 |
Why?
|
| RNA | 3 | 2012 | 1013 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2011 | 151 | 0.040 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1997 | 15 | 0.040 |
Why?
|
| Nesting Behavior | 1 | 1997 | 14 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 94 | 0.040 |
Why?
|
| Minocycline | 2 | 2010 | 182 | 0.040 |
Why?
|
| Radiation Protection | 1 | 2019 | 205 | 0.040 |
Why?
|
| Cues | 3 | 1988 | 192 | 0.040 |
Why?
|
| Action Potentials | 1 | 2020 | 560 | 0.040 |
Why?
|
| Cyclin E | 1 | 1999 | 267 | 0.040 |
Why?
|
| Rats, Inbred WF | 4 | 2002 | 22 | 0.040 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 1997 | 19 | 0.040 |
Why?
|
| Respiratory Burst | 2 | 1994 | 23 | 0.040 |
Why?
|
| Tuberculosis | 1 | 2004 | 548 | 0.040 |
Why?
|
| Adrenal Glands | 2 | 1996 | 122 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 2018 | 159 | 0.040 |
Why?
|
| Child | 2 | 2008 | 29154 | 0.040 |
Why?
|
| Attention | 1 | 1999 | 281 | 0.040 |
Why?
|
| Capsaicin | 1 | 1997 | 47 | 0.040 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2017 | 60 | 0.040 |
Why?
|
| Receptors, Interleukin-10 | 3 | 2002 | 7 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 1997 | 62 | 0.040 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 1996 | 9 | 0.040 |
Why?
|
| GABAergic Neurons | 1 | 2017 | 47 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2017 | 143 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 500 | 0.040 |
Why?
|
| Proteomics | 1 | 2024 | 1380 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 1997 | 129 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 129 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 6 | 2003 | 5395 | 0.040 |
Why?
|
| Functional Laterality | 1 | 1998 | 316 | 0.040 |
Why?
|
| Cytokinins | 2 | 2008 | 3 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1999 | 534 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 252 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1996 | 145 | 0.030 |
Why?
|
| Psychophysiology | 1 | 1995 | 16 | 0.030 |
Why?
|
| Models, Immunological | 2 | 2007 | 77 | 0.030 |
Why?
|
| Glucose | 1 | 2002 | 1248 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 1982 | 666 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1998 | 396 | 0.030 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 204 | 0.030 |
Why?
|
| Hypertension | 1 | 1985 | 1503 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2011 | 67 | 0.030 |
Why?
|
| Rodentia | 1 | 1996 | 65 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1996 | 72 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1981 | 731 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 4320 | 0.030 |
Why?
|
| Lactation | 1 | 1997 | 210 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2006 | 49 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2019 | 499 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2009 | 182 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1997 | 223 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1996 | 251 | 0.030 |
Why?
|
| Dwarfism | 1 | 1996 | 109 | 0.030 |
Why?
|
| Benzodiazepines | 3 | 1989 | 170 | 0.030 |
Why?
|
| Microinjections | 1 | 1994 | 96 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2015 | 6100 | 0.030 |
Why?
|
| Neurobiology | 1 | 1994 | 25 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 1544 | 0.030 |
Why?
|
| Chlordiazepoxide | 1 | 1974 | 3 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 1163 | 0.030 |
Why?
|
| Propranolol | 1 | 1975 | 156 | 0.030 |
Why?
|
| Neurokinin A | 1 | 1994 | 4 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2005 | 40 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2005 | 81 | 0.030 |
Why?
|
| Tacrine | 1 | 1994 | 5 | 0.030 |
Why?
|
| Parity | 2 | 1986 | 139 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 1362 | 0.030 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 2012 | 25 | 0.030 |
Why?
|
| Cell Lineage | 1 | 1997 | 668 | 0.030 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2015 | 113 | 0.030 |
Why?
|
| Rats, Inbred Lew | 2 | 2004 | 113 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 1994 | 18 | 0.030 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 1054 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 1869 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1014 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1994 | 48 | 0.030 |
Why?
|
| Clorazepate Dipotassium | 2 | 1984 | 2 | 0.030 |
Why?
|
| E2F Transcription Factors | 2 | 2004 | 132 | 0.030 |
Why?
|
| Placental Lactogen | 1 | 1993 | 7 | 0.030 |
Why?
|
| Posture | 2 | 1986 | 215 | 0.030 |
Why?
|
| Computers | 1 | 1974 | 141 | 0.030 |
Why?
|
| CDC2-CDC28 Kinases | 2 | 2004 | 129 | 0.030 |
Why?
|
| Risk Factors | 2 | 2008 | 17523 | 0.030 |
Why?
|
| Workflow | 1 | 2015 | 275 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1998 | 1385 | 0.030 |
Why?
|
| Indicators and Reagents | 2 | 2009 | 128 | 0.030 |
Why?
|
| Cell Death | 3 | 2003 | 671 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 1994 | 163 | 0.030 |
Why?
|
| Somatomedins | 1 | 1993 | 75 | 0.030 |
Why?
|
| Temperature | 3 | 1997 | 506 | 0.030 |
Why?
|
| Immunoassay | 1 | 1994 | 216 | 0.030 |
Why?
|
| Dietary Fats | 1 | 1995 | 339 | 0.030 |
Why?
|
| Injections, Subcutaneous | 3 | 1995 | 334 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 139 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 2 | 2004 | 206 | 0.030 |
Why?
|
| Phenobarbital | 2 | 1971 | 48 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 2588 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 2173 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2021 | 9244 | 0.030 |
Why?
|
| Locomotion | 1 | 1973 | 84 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2004 | 249 | 0.030 |
Why?
|
| Depression, Chemical | 3 | 1997 | 52 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1993 | 110 | 0.030 |
Why?
|
| Demography | 1 | 2014 | 435 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1992 | 58 | 0.030 |
Why?
|
| Exercise Test | 1 | 2013 | 312 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1992 | 24 | 0.030 |
Why?
|
| Caspase Inhibitors | 2 | 2003 | 95 | 0.030 |
Why?
|
| Salmonella Infections | 1 | 1992 | 40 | 0.030 |
Why?
|
| Tissue Distribution | 3 | 2000 | 875 | 0.030 |
Why?
|
| Physiology | 1 | 1972 | 17 | 0.030 |
Why?
|
| Dopaminergic Neurons | 1 | 2012 | 51 | 0.030 |
Why?
|
| Receptors, Prolactin | 1 | 1992 | 27 | 0.030 |
Why?
|
| Base Sequence | 4 | 2005 | 4917 | 0.030 |
Why?
|
| Interleukin-1 Receptor Accessory Protein | 2 | 2001 | 4 | 0.030 |
Why?
|
| Mental Fatigue | 1 | 2011 | 5 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 677 | 0.030 |
Why?
|
| Phentolamine | 1 | 2011 | 26 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 2437 | 0.030 |
Why?
|
| Psychotropic Drugs | 2 | 1992 | 133 | 0.030 |
Why?
|
| Salmonella Infections, Animal | 1 | 1991 | 9 | 0.030 |
Why?
|
| Probability Learning | 1 | 1971 | 2 | 0.030 |
Why?
|
| Mycoses | 1 | 1995 | 386 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 109 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 2001 | 300 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 1823 | 0.020 |
Why?
|
| Propanolamines | 1 | 2011 | 44 | 0.020 |
Why?
|
| Thalamus | 1 | 1972 | 132 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2004 | 2054 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 651 | 0.020 |
Why?
|
| Transcriptional Activation | 2 | 2009 | 1070 | 0.020 |
Why?
|
| Oxygenases | 1 | 2010 | 26 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 4314 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1992 | 401 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 1991 | 70 | 0.020 |
Why?
|
| Tetracycline | 1 | 1991 | 90 | 0.020 |
Why?
|
| Serine | 2 | 2003 | 388 | 0.020 |
Why?
|
| Carrageenan | 1 | 2010 | 15 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1990 | 25 | 0.020 |
Why?
|
| Adrenalectomy | 3 | 1996 | 188 | 0.020 |
Why?
|
| Olfactory Pathways | 1 | 1990 | 47 | 0.020 |
Why?
|
| Nociceptors | 1 | 1990 | 86 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2004 | 8873 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 114 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 830 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 2594 | 0.020 |
Why?
|
| Species Specificity | 2 | 2006 | 777 | 0.020 |
Why?
|
| Peroxidase | 1 | 2010 | 132 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3821 | 0.020 |
Why?
|
| DNA | 3 | 2005 | 2693 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2020 | 12873 | 0.020 |
Why?
|
| Mitogens | 2 | 1986 | 75 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 1213 | 0.020 |
Why?
|
| Sodium Chloride | 2 | 1987 | 156 | 0.020 |
Why?
|
| Receptors, Interleukin-4 | 2 | 1999 | 22 | 0.020 |
Why?
|
| Etanercept | 1 | 2009 | 54 | 0.020 |
Why?
|
| Parasympathomimetics | 1 | 1989 | 8 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2009 | 44 | 0.020 |
Why?
|
| Carcinoma | 1 | 2001 | 2578 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 2 | 1999 | 51 | 0.020 |
Why?
|
| Research Personnel | 1 | 2010 | 156 | 0.020 |
Why?
|
| Phosphotyrosine | 2 | 2000 | 111 | 0.020 |
Why?
|
| Cell Count | 2 | 2002 | 508 | 0.020 |
Why?
|
| Biological Factors | 1 | 1989 | 45 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 2000 | 329 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 203 | 0.020 |
Why?
|
| Receptors, Angiotensin | 2 | 1985 | 44 | 0.020 |
Why?
|
| Cholecalciferol | 2 | 1999 | 46 | 0.020 |
Why?
|
| Ribavirin | 1 | 2009 | 178 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 323 | 0.020 |
Why?
|
| Software | 1 | 2016 | 1321 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 445 | 0.020 |
Why?
|
| Sleep | 1 | 2011 | 413 | 0.020 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2007 | 7 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2007 | 29 | 0.020 |
Why?
|
| Premedication | 1 | 2008 | 135 | 0.020 |
Why?
|
| DNA Fragmentation | 2 | 1999 | 198 | 0.020 |
Why?
|
| Brain Stem | 1 | 2008 | 175 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 14551 | 0.020 |
Why?
|
| Proteins | 3 | 2001 | 1963 | 0.020 |
Why?
|
| Testis | 1 | 1992 | 717 | 0.020 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2007 | 8 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 2 | 1999 | 367 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2002 | 1546 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2007 | 60 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 2 | 1984 | 10 | 0.020 |
Why?
|
| Neutrophils | 1 | 1992 | 835 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2007 | 25 | 0.020 |
Why?
|
| Housing, Animal | 1 | 1987 | 38 | 0.020 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1987 | 26 | 0.020 |
Why?
|
| Flow Cytometry | 3 | 1999 | 3033 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 1989 | 225 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 50 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 4298 | 0.020 |
Why?
|
| Diaphragm | 2 | 2000 | 181 | 0.020 |
Why?
|
| Binding Sites | 2 | 2001 | 2171 | 0.020 |
Why?
|
| Brain Mapping | 1 | 1990 | 644 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 45 | 0.020 |
Why?
|
| Anisomycin | 1 | 2006 | 11 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 5377 | 0.020 |
Why?
|
| Oxytocin | 1 | 1987 | 62 | 0.020 |
Why?
|
| Flumazenil | 2 | 1984 | 8 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2006 | 34 | 0.020 |
Why?
|
| Receptor, trkB | 1 | 2006 | 53 | 0.020 |
Why?
|
| Sphingosine | 1 | 2006 | 55 | 0.020 |
Why?
|
| Xylazine | 1 | 1986 | 2 | 0.020 |
Why?
|
| Lameness, Animal | 1 | 1986 | 4 | 0.020 |
Why?
|
| Tail | 1 | 1986 | 28 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 224 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 2422 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2006 | 165 | 0.020 |
Why?
|
| Apomorphine | 1 | 1985 | 12 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 626 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 1997 | 573 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2005 | 8 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2005 | 13 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 4549 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 299 | 0.020 |
Why?
|
| Growth Cones | 1 | 2005 | 20 | 0.020 |
Why?
|
| Reflex | 1 | 1986 | 68 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2003 | 2084 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2005 | 73 | 0.020 |
Why?
|
| Gliosis | 1 | 2005 | 41 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2006 | 193 | 0.020 |
Why?
|
| Biotin | 1 | 2005 | 69 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 1985 | 47 | 0.020 |
Why?
|
| Tritium | 1 | 2005 | 200 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2005 | 113 | 0.020 |
Why?
|
| Hydroxydopamines | 1 | 1985 | 5 | 0.020 |
Why?
|
| Piperazines | 2 | 2005 | 2101 | 0.020 |
Why?
|
| Seizures | 2 | 1985 | 989 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 157 | 0.020 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1985 | 16 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 2508 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1990 | 1130 | 0.020 |
Why?
|
| Hemocyanins | 1 | 2004 | 50 | 0.020 |
Why?
|
| Lectins | 1 | 2005 | 151 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2001 | 1062 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 1984 | 79 | 0.020 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 1 | 1984 | 6 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1984 | 19 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2004 | 36 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2005 | 87 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 2 | 2019 | 5061 | 0.020 |
Why?
|
| Taste Disorders | 1 | 2004 | 17 | 0.020 |
Why?
|
| Interphase | 1 | 2004 | 145 | 0.020 |
Why?
|
| Peptidoglycan | 1 | 2004 | 14 | 0.020 |
Why?
|
| Friends | 1 | 2004 | 24 | 0.020 |
Why?
|
| Angiotensin II | 1 | 1985 | 198 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2004 | 72 | 0.020 |
Why?
|
| Tuberculin | 1 | 2004 | 18 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 57 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 460 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 3552 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 1984 | 61 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2005 | 231 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2003 | 107 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 1996 | 6089 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2003 | 191 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2003 | 136 | 0.010 |
Why?
|
| Capillaries | 1 | 2003 | 99 | 0.010 |
Why?
|
| Epilepsy | 1 | 1971 | 883 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2004 | 158 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 1487 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 170 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 1985 | 218 | 0.010 |
Why?
|
| Plasma | 1 | 2004 | 158 | 0.010 |
Why?
|
| Chromones | 1 | 2003 | 120 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 459 | 0.010 |
Why?
|
| Biological Assay | 1 | 2004 | 177 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2004 | 15694 | 0.010 |
Why?
|
| Odorants | 1 | 2003 | 73 | 0.010 |
Why?
|
| Pentylenetetrazole | 1 | 1982 | 29 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 323 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 445 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 974 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1983 | 281 | 0.010 |
Why?
|
| Infrared Rays | 2 | 1972 | 54 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2009 | 1230 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2002 | 54 | 0.010 |
Why?
|
| Cattle Diseases | 1 | 1982 | 22 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2001 | 54 | 0.010 |
Why?
|
| Piroxicam | 2 | 1992 | 5 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 886 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 165 | 0.010 |
Why?
|
| Catecholamines | 1 | 1982 | 101 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 249 | 0.010 |
Why?
|
| Hematocrit | 1 | 2002 | 142 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 471 | 0.010 |
Why?
|
| Zinc | 2 | 1993 | 188 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2001 | 94 | 0.010 |
Why?
|
| Morpholines | 1 | 2003 | 289 | 0.010 |
Why?
|
| Preoptic Area | 1 | 2000 | 7 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 1618 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2002 | 234 | 0.010 |
Why?
|
| Neuroblastoma | 2 | 1998 | 686 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2001 | 256 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1982 | 294 | 0.010 |
Why?
|
| Oncogene Protein v-akt | 1 | 2000 | 101 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1980 | 114 | 0.010 |
Why?
|
| Diffusion | 1 | 2000 | 88 | 0.010 |
Why?
|
| Immune Sera | 1 | 2000 | 146 | 0.010 |
Why?
|
| Esterases | 1 | 1999 | 19 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2001 | 360 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1537 | 0.010 |
Why?
|
| Dextrans | 1 | 2000 | 90 | 0.010 |
Why?
|
| Psychometrics | 1 | 2004 | 937 | 0.010 |
Why?
|
| Reproduction | 1 | 1982 | 253 | 0.010 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 1999 | 86 | 0.010 |
Why?
|
| Thymidine | 1 | 1999 | 155 | 0.010 |
Why?
|
| Neuritis | 1 | 1999 | 4 | 0.010 |
Why?
|
| Ependyma | 1 | 1999 | 13 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1999 | 53 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 891 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2001 | 429 | 0.010 |
Why?
|
| Blood Pressure | 4 | 1986 | 1467 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 549 | 0.010 |
Why?
|
| Insulinoma | 1 | 1998 | 55 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 287 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1998 | 43 | 0.010 |
Why?
|
| Sirolimus | 1 | 2003 | 814 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 3438 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 597 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 377 | 0.010 |
Why?
|
| Oscillometry | 1 | 1978 | 26 | 0.010 |
Why?
|
| Myocardium | 1 | 2004 | 1313 | 0.010 |
Why?
|
| Glycerol | 1 | 1998 | 99 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 1259 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1999 | 311 | 0.010 |
Why?
|
| Catheterization | 1 | 2000 | 410 | 0.010 |
Why?
|
| Lipolysis | 1 | 1998 | 108 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 980 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 1998 | 91 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1997 | 74 | 0.010 |
Why?
|
| Grooming | 1 | 1997 | 9 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1997 | 17 | 0.010 |
Why?
|
| Thiazoles | 1 | 2002 | 726 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1997 | 80 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1997 | 112 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 1997 | 101 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 204 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32848 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1979 | 218 | 0.010 |
Why?
|
| Abdomen | 1 | 1999 | 332 | 0.010 |
Why?
|
| Isomerism | 1 | 1996 | 63 | 0.010 |
Why?
|
| Appetite Depressants | 1 | 1996 | 21 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1997 | 107 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 3101 | 0.010 |
Why?
|
| Leptin | 1 | 1998 | 295 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1997 | 153 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 1996 | 3 | 0.010 |
Why?
|
| Poultry | 1 | 1976 | 10 | 0.010 |
Why?
|
| Adipocytes | 1 | 1998 | 305 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1997 | 684 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 1997 | 228 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1996 | 60 | 0.010 |
Why?
|
| Cell Communication | 1 | 1998 | 509 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 1996 | 89 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 682 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 621 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 153 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 4233 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2002 | 1555 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 5673 | 0.010 |
Why?
|
| Neoplasm Proteins | 2 | 1998 | 3230 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1998 | 482 | 0.010 |
Why?
|
| Lithium Chloride | 2 | 1985 | 28 | 0.010 |
Why?
|
| Animal Feed | 1 | 1975 | 81 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 1997 | 359 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 6295 | 0.010 |
Why?
|
| Psychopharmacology | 1 | 1974 | 13 | 0.010 |
Why?
|
| beta-Endorphin | 2 | 1985 | 42 | 0.010 |
Why?
|
| Lithium | 2 | 1985 | 71 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 1818 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 406 | 0.010 |
Why?
|
| Habituation, Psychophysiologic | 1 | 1974 | 19 | 0.010 |
Why?
|
| Veterinary Medicine | 1 | 1974 | 9 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1994 | 184 | 0.010 |
Why?
|
| Chlorides | 2 | 1985 | 139 | 0.010 |
Why?
|
| Auditory Perception | 1 | 1974 | 35 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 6009 | 0.010 |
Why?
|
| Glioma | 1 | 2005 | 1963 | 0.010 |
Why?
|
| Weight Gain | 1 | 1997 | 464 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1974 | 255 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1974 | 118 | 0.010 |
Why?
|
| Research Design | 1 | 2001 | 1544 | 0.010 |
Why?
|
| Phagocytes | 1 | 1993 | 44 | 0.010 |
Why?
|
| Obesity | 1 | 2006 | 2884 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 2944 | 0.010 |
Why?
|
| Autoradiography | 1 | 1993 | 132 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1976 | 288 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 568 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 1555 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 264 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1996 | 1008 | 0.010 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1972 | 59 | 0.010 |
Why?
|
| Macrophages, Alveolar | 1 | 1992 | 67 | 0.010 |
Why?
|
| Transplantation, Heterotopic | 1 | 1992 | 43 | 0.010 |
Why?
|
| Immunity, Cellular | 2 | 1985 | 419 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 189 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1992 | 61 | 0.010 |
Why?
|
| Amphetamine | 1 | 1971 | 19 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 5687 | 0.010 |
Why?
|
| Copper | 1 | 1993 | 165 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1998 | 1682 | 0.010 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1993 | 125 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1992 | 217 | 0.010 |
Why?
|
| Television | 1 | 1972 | 74 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1995 | 621 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1992 | 260 | 0.010 |
Why?
|
| Electrocoagulation | 1 | 1971 | 65 | 0.010 |
Why?
|
| Drug Approval | 1 | 1992 | 178 | 0.010 |
Why?
|
| Liposomes | 1 | 1992 | 684 | 0.010 |
Why?
|
| Water Loss, Insensible | 1 | 1970 | 3 | 0.010 |
Why?
|
| Atmospheric Pressure | 1 | 1970 | 8 | 0.010 |
Why?
|
| Injections | 1 | 1991 | 285 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1992 | 503 | 0.010 |
Why?
|
| Humidity | 1 | 1970 | 29 | 0.010 |
Why?
|
| Body Water | 1 | 1970 | 132 | 0.010 |
Why?
|
| Epithelium | 1 | 1992 | 720 | 0.010 |
Why?
|
| Iron | 1 | 1993 | 376 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1990 | 208 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1997 | 2358 | 0.010 |
Why?
|
| Arecoline | 1 | 1989 | 2 | 0.010 |
Why?
|
| Necrosis | 1 | 1991 | 580 | 0.010 |
Why?
|
| Carbolines | 1 | 1989 | 27 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1989 | 61 | 0.010 |
Why?
|
| Arginine | 1 | 1992 | 500 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 4849 | 0.010 |
Why?
|
| Cyclophosphamide | 2 | 1986 | 3001 | 0.000 |
Why?
|
| Respiration | 1 | 1970 | 447 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1991 | 750 | 0.000 |
Why?
|
| Phytohemagglutinins | 1 | 1986 | 71 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1986 | 67 | 0.000 |
Why?
|
| Haplorhini | 1 | 1986 | 130 | 0.000 |
Why?
|
| Feces | 1 | 1970 | 770 | 0.000 |
Why?
|
| Sensory Thresholds | 1 | 1986 | 68 | 0.000 |
Why?
|
| Diuresis | 1 | 1985 | 63 | 0.000 |
Why?
|
| Sheep | 1 | 1986 | 258 | 0.000 |
Why?
|
| Hypertonic Solutions | 1 | 1985 | 31 | 0.000 |
Why?
|
| Predatory Behavior | 1 | 1985 | 13 | 0.000 |
Why?
|
| Flunitrazepam | 1 | 1985 | 3 | 0.000 |
Why?
|
| Muscle Tonus | 1 | 1985 | 13 | 0.000 |
Why?
|
| Water Deprivation | 1 | 1985 | 5 | 0.000 |
Why?
|
| Oxidopamine | 1 | 1985 | 15 | 0.000 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1985 | 7 | 0.000 |
Why?
|
| Receptors, Dopamine | 1 | 1985 | 42 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 7789 | 0.000 |
Why?
|
| Water-Electrolyte Balance | 1 | 1985 | 104 | 0.000 |
Why?
|
| Blood Volume | 1 | 1985 | 100 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1975 | 3719 | 0.000 |
Why?
|
| Agonistic Behavior | 1 | 1983 | 10 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1985 | 931 | 0.000 |
Why?
|
| Lymphoma | 1 | 1992 | 1467 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 4557 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1987 | 1271 | 0.000 |
Why?
|
| Prostate | 1 | 1986 | 1088 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1986 | 1294 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1984 | 1375 | 0.000 |
Why?
|